Connecticut State Department of Children and Families

NOTICE: If you are looking for ways to donate to children and families involved with DCF during the holiday's, please contact: Jacqueline Ford, MSW, via email - Jacqueline.ford@ct.gov. JACQUELINE.FORD@ct.gov

Psychotropic Medication Advisory Committee (PMAC)

PMAC E-Mail:  getmeds.dcf@ct.gov

The FDA Warns Against the Use of Many Genetic Tests with Unapproved Claims to Predict Patient Response to Specific Medications: FDA Safety Communication

2019 Minutes

October
September
May
April
March
February
January

2018 Minutes

December
November
October
May
April
March
February

Handouts:

Appendix II Psychotropic Medication Monitoring Protocols (November 2019)
CYP Metabolism of Psychotropic Medications 
DCF and PMAC Position Paper on Supplements (September 2019)
Drug Review and Decision History by Date (July 2015)
Drug Review and Decision History by Drug (July 2015)
Drug Lists:
     Brand Name/Generic Name Drug List (June 2016)
     Generic Name/Brand Name Drug List (June 2016)
Guidelines for Psychotropic Medication Use in Children and Adolescents

 

 

 

 

 

 

 

 

 

 

 

DCF and PMAC position paper on supplements edited 9619